In our inaugural International Spotlight, Dr. Hathal Haddad of University Hospital Tübingen discusses advances in prostate brachytherapy — from prostate artery embolization (PAE) to AI-assisted workflows. A leader in interventional radiotherapy, he shares how his team is shaping the future of precision care in Germany and beyond.

Dr. Manuj Agarwal joins the ABS Podcast for Prostate Cancer Awareness Month to discuss life after prostate cancer treatment, minimizing ADT side effects, and optimizing long-term health. He shares insights from thousands of cases and his work in integrative oncology and longevity medicine.

As presented on June 20, 2025 at the ABS Annual Conference

Live from the ABS,  Dr. Cate Yashar and Dr. Mitch Kamrava as brachytherapy thought leaders join Dr. Matt Harkenrider for a lively discussion spanning a range of topics about the future of brachytherapy.  We discuss how to work at an institutional level to develop and advocate for a brachytherapy program and then how, we as a specialty, need to teach, research, and innovate for brachytherapy of the future.  The future of brachytherapy is bright!

Dr. Elizabeth Kidd and Dr. Santino Butler are co-primary authors of the recent manuscript entitled “Image guided cervical brachytherapy practice patterns: 2023/2024 survey of the American Brachytherapy Society” that was recenlty published in the Brachytherapy Journal.  In this episode, we discuss how the landscape of cervical cancer brachytherapy has evolved in the last decade including some provocative thoughts where we are heading in the coming years.  Drs Kidd and Butler also go beyond just practice patterns and give some insights into best practices in the management of cervical cancer patients.

In this episode of the American Brachytherapy Society podcast, we sit down with Michael Krachon, President of Theragenics International, and Lory Bradley, a seasoned industry expert with decades of experience in prostate brachytherapy. Together, they reflect on the evolution of the field—from the early days of seed implants to modern-day innovations and challenges.

Michael shares insights from his long career in the prostate seed business, highlighting the pivotal role of physician partnerships, the rise and fall of brachytherapy utilization, and the path forward for restoring its prominence in prostate cancer care. Lory offers additional perspective on the clinical and logistical advancements that have shaped practice patterns over time.

Whether you're a clinician, trainee, or industry partner, this episode provides valuable historical context, practical wisdom, and a hopeful outlook for the future of LDR brachytherapy.

On this episode of the ABS Podcast, Dr. Gita Suneja and Dr. Cristina DeCesaris join Dr. Harkenrider to discuss the quality of life and financial analyses of the SAVE trial. The SAVE trial randomized patients to a 2 fraction regimen vs a standard of care regimen of VBT with an emphasis on pragmatic design and inclusive enrollment to measure patient centered outcomes.  Join our lively discussion on trial design and creating treatment options that matter for patients!

In this episode of the American Brachytherapy Society podcast, Dr. Alexandra Stewart, Consultant Clinical Oncologist at the Royal Surrey, discusses the evolving role of rectal brachytherapy in non-operative management of rectal cancer. Drawing from her expertise and international experience, Dr. Stewart explores key findings from the OPERA trial, patient selection criteria, dosing strategies, and the latest advancements in contact X-ray brachytherapy (CXB) techniques. She also highlights the impact of treatment protocols on clinical outcomes and future directions, including insights into the TRESOR trial. Tune in for an in-depth conversation on how brachytherapy is shaping the future of rectal cancer care.

In this episode, our guests Dr. Supriya Chopra and Dr. Remi Nout discuss BioEMBRACE and the evolving landscape of biomarkers in locally advanced cervical cancer. As thought leaders in the field, Drs. Chopra and Nout give their insights on the future of biomarker-driven therapy in cervical cancer with a continued emphasis on high quality brachytherapy as we move in this direction. 

In this episode of the ABS podcast, Dr. Matthew Harkenrider sits down with Dr. Kathy Han from Princess Margaret Hospital and University of Toronto to discuss her recent manuscript entitled “Clinical Outcomes of 3 Versus 4 Fractions of Magnetic Resonance Image-Guided Brachytherapy in Cervical Cancer."  They discuss the decision making of dose-fractionation regimens that fit the resources available at a given center and the challenges that accompany the management of cervical cancer patients.  Additionally, they discuss best practices in cervical cancer brachytherapy and procedural and planning techniques to optimize patient outcomes. 

In this episode of the ABS podcast, Dr. Manuj Agarwal and Dr. Rebecca Krc dive into the transformative 300 in 10 initiative, a groundbreaking effort by the American Brachytherapy Society to reverse declining brachytherapy utilization. Dr. Agarwal provides an overview of the initiative’s origins, the ABS Board of Directors’ 10-year vision, and the program’s goals to train 30 competent brachytherapy teams annually through a comprehensive approach.

Dr. Krc shares her personal journey with the initiative, reflecting on her experiences as a participant and how the program has prepared her to overcome barriers to establishing a successful brachytherapy practice. Together, they discuss the program’s role in addressing gaps in training caused by low institutional brachytherapy volume and its potential to shape the future of the field.

 Learn more and apply for the fellowship: https://www.americanbrachytherapy.org/resources/fellowships/300-in-10-2-month-fellowship/